Newsletter Subject

Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Wed, May 15, 2024 10:46 PM

Email Preheader Text

Daily Headlines Wednesday, May 15, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Wednesday, May 15, 2024 Today's Top Stories for {NAME} [ONCOLOGY/HEMATOLOGY]( [Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer]( [NEUROLOGY]( [Andexanet Shows Efficacy in Acute ICH With Factor Xa Inhibitors]( [INFECTIOUS DISEASE]( [HHS Suspends Federal Funding for Group Tied to Wuhan Lab]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Expert Insight Into von Hippel-Lindau (VHL) Disease: From Symptoms and Diagnosis to Cutting-Edge Therapies and Adverse Event Management]( [SPECIAL REPORTS]( [Over 400 Physicians From Delaware's ChristianaCare Move to Unionize]( [SPECIAL REPORTS]( [New Mexico a Safe Haven for Trans Youth]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [WASHINGTON-WATCH]( [HHS Task Force Launches Roadmap for Improving Maternal Mental Health]( CME SPOTLIGHT [Navigating Transitions to Adult Care for Sickle Cell Disease: A Toolkit for Healthcare Providers and Their Patients]( [MEETING COVERAGE]( [Step-Down Antiplatelet Strategy Pairs Well With DCB Angioplasty]( [INFECTIOUS DISEASE]( [There's Bird Flu in U.S. Dairy Cows. Raw Milk Drinkers Aren't Deterred.]( [PERSPECTIVES]( [Healthcare Needs Qualified Expert Witnesses More Than Ever]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing the Application of the Latest Clinical Data in Secondary AML]( [RHEUMATOLOGY]( [One-Year Data Back Upadacitinib for Clinical Spondyloarthritis]( [ENDOCRINOLOGY]( [Smartphone-Based Lifestyle Interventions Result in Modest, Sustained Weight Loss]( [OB/GYN]( [FDA Approves New Self-Collection Option for HPV Testing]( CME SPOTLIGHT [Latest Evidence for Treating Secondary AML]( [PRACTICE MANAGEMENT]( [Taking Telemedicine Visits From Your Kitchen? Think Again]( [MEETING COVERAGE]( [Bicuspid Anatomy: Wrench Thrown in TAVR for Younger, Low-Risk Patients?]( [PSYCHIATRY]( [FDA Panel to Weigh In on MDMA Approval; Parents Lost to Overdose; New APA President]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [PSYCHIATRY]( [Obesity, Low Body Mass Linked to Mental Health Concerns in Adolescents]( [ONCOLOGY/HEMATOLOGY]( [Resection for Early Liver Cancer Tied to Improved Survival]( [INFECTIOUS DISEASE]( [COVID Still Deadlier Than the Flu -- But the Gap Is Narrowing]( CME SPOTLIGHT [Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm]( [AAD READING ROOM]( [Rituximab May Be More Effective as First-Line Therapy for Pemphigus]( [PSYCHIATRY]( [U.S. Overdose Deaths Dropped in 2023, but Experts Say It's Too Soon to Celebrate]( [SPOTLIGHT ON]( [Progression Independent of Relapse Activity in Multiple Sclerosis]( [MEDICAL JOURNEYS]( [Case Study: High Lipoprotein(a) Levels in Younger Patients Are Not So Clear Cut]( Industry Clinic AD INSIGHTS [Recognizing Racial Disparities Impacting Rare Kidney Disease Patients]( # Weekly Survey [Anxious Without Your Phone?]( More than 99% of healthcare providers met criteria for nomophobia (fear of being without a mobile phone), according to a [new survey]([VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-05-15&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.